British Life Science Investor Syncona Unit Raises $170M
Medical technology company Beacon Therapeutics has raised approximately £134 million ($170 million) in its second round of funding from new and existing investors including venture capital firms and the University of...To view the full article, register now.
Already a subscriber? Click here to view full article